Literature DB >> 12107736

Lipoprotein lipase gene variants relate to presence and degree of microalbuminuria in Type II diabetes.

R K Mattu1, J Trevelyan, E W A Needham, M Khan, M A Adiseshiah, D Richter, R G Murray, D J Betteridge.   

Abstract

AIMS/HYPOTHESIS: Lipids and lipoproteins, particularly triglyceride rich lipoproteins, could influence the development and progression of microalbuminuria in diabetes. Lipoprotein lipase gene variants have been found to correlate with lipid/lipoprotein concentrations, especially hypertriglyceridaemia. We assessed the influence of this gene on microalbuminuria in Type II (insulin-dependent) diabetes mellitus.
METHODS: Microalbuminuria was determined quantitatively in 386 sequential Type II diabetic patients by measurement of the albumin-to-creatinine ratio (ACR). DNA was analysed for two common intronic LPL single nucleotide polymorphisms (Pvu II, intron 6, and Hind III, intron 8), and three common exonic mutations (Asp(9)-Asn, exon 2, Asn(291)-Ser, exon 6, and Ser(447)-Ter, exon 9).
RESULTS: Individuals with P (2) P (2) (Pvu II) and H (2) H (2) (Hind III) genotypes had significantly greater ACRs ( P(2)P(2) vs P(1)P(1)+ P(1)P(2), 5.0+/-0.5 vs 3.4+/-0.3, p=0.0004 and H(2)H(2) vs H(1)H(1)+ H(1)H(2), 4.3+/-0.4 vs 3.4+/-0.3, p=0.04). Logistic regression analysis demonstrated that only the P(2)P(2) genotype ( p=0.0004), systolic BP ( p=0.008) and creatinine ( p=0.031) were independently associated with the presence of microalbuminuria/proteinuria. P(2) homozygotes were 170% more likely to have microalbuminuria or proteinuria, O.R. 2.7 (1.6-4.5, p=0.0001), 150% more likely to have microalbuminuria, O.R. 2.5 (1.5-4.3, p=0.001), and 330% more likely to have proteinuria, O.R. 4.3 (1.6-11.4, p=0.004). There were no associations of microalbuminuria with any of the exonic polymorphisms. CONCLUSION/
INTERPRETATION: Genetic variants of lipoprotein lipase correlate with presence and severity of microalbuminuria in Type II diabetes, independent of effect on serum lipids. This association is only apparent in genetic variants demonstrating greatest heterozygosity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12107736     DOI: 10.1007/s00125-002-0824-7

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  4 in total

1.  Association of lipoprotein lipase (LPL) single nucleotide polymorphisms with type 2 diabetes mellitus.

Authors:  Yoon Shin Cho; Min Jin Go; Hye Ree Han; Seung Hun Cha; Hung Tae Kim; Haesook Min; Hyoung Doo Shin; Chan Park; Bok Ghee Han; Nam Han Cho; Chol Shin; Kuchan Kimm; Bermseok Oh
Journal:  Exp Mol Med       Date:  2008-10-31       Impact factor: 8.718

2.  Association of CC chemokine ligand 5 genotype with urinary albumin excretion in the non-diabetic Japanese general population: the Takahata study.

Authors:  Tsuneo Konta; Mitsuru Emi; Sayumi Toriyama; Hideto Ariumi; Miho Ishii; Satoshi Takasaki; Ami Ikeda; Kazunobu Ichikawa; Yoko Shibata; Noriaki Takabatake; Yasuchika Takeishi; Takeo Kato; Sumio Kawata; Isao Kubota
Journal:  J Hum Genet       Date:  2008-01-24       Impact factor: 3.172

3.  High fat diet modifies the association of lipoprotein lipase gene polymorphism with high density lipoprotein cholesterol in an Asian Indian population.

Authors:  K A Ayyappa; I Shatwan; D Bodhini; L R Bramwell; K Ramya; V Sudha; R M Anjana; J A Lovegrove; V Mohan; V Radha; K S Vimaleswaran
Journal:  Nutr Metab (Lond)       Date:  2017-01-19       Impact factor: 4.169

Review 4.  Circulatory syndrome: an evolution of the metabolic syndrome concept!

Authors:  Ali Reza Khoshdel; Shane L Carney; Alastair Gillies
Journal:  Curr Cardiol Rev       Date:  2012-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.